
Background: Neonatal bullous pneumopathy is a severe complication of staphylococcal respiratory infection, traditionally attributed to strains producing Panton-Valentine leukocidin (PVL). Clinically indistinguishable disease nonetheless arises with PVL-negative strains, creating a diagnostic paradox with immediate therapeutic consequences. Methods: We report an index case of PVL-negative bullous pneumopathy in an infant born at 32 weeks’ gestation and analyze it through 5 falsifiable mechanistic hypotheses, derived from a structured literature synthesis (72 sources, updated June 29, 2026) and Monte Carlo modeling (10,000 iterations), organized as a Lakatosian research program and appraised against independent datasets. Results: The analysis indicates that alpha-hemolysin (Hla; ∼95% of strains vs. 2% to 5% for PVL) is the principal alternative effector of injury; that neonatal NLRP3 inflammasome hyperactivation amplifies tissue destruction; that preterm surfactant deficiency removes a protective barrier; that phenol-soluble modulins contribute to necrosis; and that PVL detection can generate false negatives. Modeling estimated the probability of severe disease at 0.73 (95% CI: 0.68-0.78), with mortality falling from 25.6% without antitoxin therapy to 5.5% with a protein-synthesis inhibitor plus intravenous immunoglobulin. Conclusions: A negative PVL test must not reassure the clinician facing neonatal necrotizing pneumonia; toxin-suppressive therapy should be considered irrespective of PVL status, within a multimarker diagnostic strategy.
Intravenous immunoglobulins (IVIGs) are a cornerstone of immunologic therapy in pediatric conditions. Particular attention has been directed toward IgM- and IgA-enriched IVIG (IGAM), a formulation that differs from conventional IVIG because of its greater immunomodulatory activity. We describe a clinical case in which early immunomodulatory therapy with enriched immunoglobulins resulted in a favorable outcome. A 12-year-old boy presented to the pediatric emergency department with a 2-day history of fever and difficulty walking. Examination revealed pain on movement of the left lower limb and a warm, swollen, tender left knee with cutaneous hyperesthesia. Laboratory tests showed elevated inflammatory markers. Magnetic resonance imaging demonstrated a collection in the popliteal region extending to the left thigh, involving the vastus medialis muscle. Blood cultures were positive for methicillin-resistant Staphylococcus aureus . The patient received antibiotic therapy and Pentaglobin. This case suggests that early IGAM infusion in patients with infectious hyperinflammation may represent an effective therapeutic strategy.
Background: Dalbavancin, a long-acting lipoglycopeptide antibiotic, is increasingly used off-label as chronic suppressive therapy for infections involving retained prosthetic material. However, data on infectious complications during long-term use remain limited. Material and Methods: This is a retrospective, multicenter cohort study in 4 hospitals in south-eastern Spain, including adult patients treated with dalbavancin for over 12 weeks. Clinical, microbiological, and therapeutic data were collected. The primary endpoint was superinfection-related hospitalization; secondary outcomes included infectious complications, infection resolution, recurrence, and mortality. Patients were stratified by treatment duration (3 to 6, 6 to 12, or >12 mo). Results: Among 274 patients who received dalbavancin, 21 met the inclusion criteria. Most infections were prosthetic joint-related (33.3%), with Staphylococcus epidermidis as the most common pathogen (33.3%). Superinfections occurred in 47.6%, more often with longer treatment (71.4% at 6 to 12 mo; 50% at >12 mo; vs. 16.7% at 3 to 6 mo), with no significant trend and weak correlation with treatment length. They were mainly caused by gram-negative bacteria (38.1%) and were associated with bacteremia and urinary tract infections. Infection resolution after 1-year post-treatment follow-up was achieved in 57.1% of cases, including all patients treated for 3 to 6 months. No treatment discontinuations due to adverse effects were recorded. Conclusions: These findings suggest that dalbavancin is a safe and potentially effective long-term suppressive option for selected patients, especially those with retained prosthetic material and no surgical alternative. Nonetheless, the increased frequency of superinfections in longer treatments warrants further investigation. Prospective studies are needed to confirm these observations and define the benefit-risk balance.
Background: Asymptomatic bacteriuria (ASB) is a driver of unnecessary antimicrobial use in hospitals. Despite recommendations against screening and treating most patients with ASB, inappropriate urine culture ordering and antibiotic prescribing remain common. This study assessed healthcare professionals’ knowledge, attitudes, and practices regarding ASB and identified behavioral determinants relevant to diagnostic and antimicrobial stewardship. Methods: A cross-sectional questionnaire-based survey was conducted among physicians, nurses, and microbiologists at a tertiary care hospital in India. A structured questionnaire that underwent expert face and content validation assessed knowledge, attitudes, perceived barriers, and profession-specific practices. Behavioral determinants were mapped using the Capability-Opportunity-Motivation Behavior (COM-B) framework. Data were analyzed descriptively. Results: A total of 515 healthcare professionals participated. Although 95% reported awareness of the distinction between urinary tract infection and ASB, and 89% reported knowing when bacteriuria should be treated, only 11% were aware of guideline recommendations. The overall mean knowledge score was 3.3/10. Among physicians, 62% reported treating ASB in all patients and 34% documented urine culture indications. Among nurses, 54% reported collecting urine from the collection bag, and 15.5% consistently performed hand hygiene before and after catheter insertion. Fear of poor patient outcomes if ASB remained untreated (69%), inadequate understanding of guideline recommendations (68%), and lack of time (62%) were the most frequently reported barriers; 99% supported diagnostic stewardship initiatives. Conclusions: Knowledge gaps and practice variation in ASB management are substantial across healthcare professionals. A coordinated multidisciplinary approach is needed to address these multifactorial barriers and improve stewardship.
Neurosyphilis may mimic inflammatory and demyelinating disorders, particularly when cerebrospinal fluid (CSF) abnormalities are minimal. We report a 17-year-old postpartum adolescent who developed progressive paraparesis, sensory deficits, gait instability, and headache 34 days after delivery following treatment for gestational syphilis during pregnancy. Brain magnetic resonance imaging demonstrated a solitary pontine T2-hyperintense lesion without significant enhancement, initially suggesting an inflammatory demyelinating process. CSF analysis revealed a protein concentration of 24.9 mg/dL and only 2 leukocytes/mm³. Despite these minimally inflammatory findings, CSF Venereal Disease Research Laboratory testing was reactive at a titer of 1:16, supporting the diagnosis of neurosyphilis in the appropriate clinical context. The patient experienced marked neurologic improvement following intravenous aqueous crystalline penicillin G therapy. This case highlights postpartum neurosyphilis as an uncommon demyelinating mimic and underscores the importance of syphilis testing in patients with unexplained focal neurologic syndromes despite near-normal CSF findings.